Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taste Assessment of Tricaprilin Powder
NCT03628352Phase 1Completed
- Sponsor
- Cerecin
- Start
- Sep 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tricaprilin in Alzheimer's disease (AD), sponsored by Cerecin. Primary endpoints: Taste assessment at 1 day, Smell assessment at 1 day and 2 more. Started Sep 2018; status: completed.
02
Drugs
tricaprilin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03628352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03628352.